research Cutaneous complications of chemotherapeutic agents
Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research Female pattern hair loss
FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.
research ASPECTOS DA ESTRONGILOIDÍASE EM CÃES E O SEU IMPACTO NO ÂMBITO DA SAÚDE PÚBLICA
Dogs can transmit a parasite to humans, especially affecting those with weak immune systems, so early diagnosis and treatment are crucial.
research OCORRÊNCIA DA GIARDÍASE EM CÃES E A SUA RELEVÂNCIA PARA A SAÚDE PÚBLICA
Giardiasis in dogs poses a public health risk, requiring better diagnosis, treatment, and sanitation.
research Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
Technology, like mobile apps and AI, is improving skin condition diagnosis and treatment.
research MECHANISM OF PROTEINURIA
Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.
research Kombinasi nanoemulsi Minyak Kemiri (Aleurites mollucana L.) dan Serbuk Daun seledri (Apium graveolens L.) pada Model Penyakit Alopesia
Candlenut oil and celery powder improved hair growth and could be a potential treatment for alopecia.
research Standardization of Clinical Photos for Tracking Management of Hair Loss in Dermatology Clinics
Standardized photos improve hair loss treatment and patient care.
research A Comparative Clinical study of Nasya Karma and Shirodhara with Yashtimadhwadi tail for the management of Khalitya with special reference to "Telogen effluvium"
Both Ayurvedic treatments improved hair fall, with Shirodhara being especially effective.
research Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.